Amalia Enríquez-de-Salamanca is a principal investigator at Ocular Surface group at the Institute of Applied Opthalmobiology (IOBA), University of Valladolid, Valladolid Spain, and researcher from the Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). She is also Director of the Ocular-facial pain unit at the IOBA. She graduated in Biochemistry (1992) and has a Ph.D. in Biochemistry (1998) (Complutense University, UCM; Madrid, Spain). She has authored 55 articles in peer-reviewed journals. She has directed six doctoral theses and currently co-directs four more in progress. Her main research field is the characterization of potential biomarkers in tears and/or epithelial cells in immune-based chronic inflammatory diseases of the ocular surface, such as dry eye syndrome and in ocular chronic pain. Her research also includes the study of the role of corneal and conjunctival epithelial cells in these diseases. She is a member of the Association for Research in Vision and Ophthalmology (ARVO).